相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation
Benjamin Izar et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab
Yoshinobu Koguchi et al.
CANCER RESEARCH (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
Ludovic Martinet et al.
CELL REPORTS (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
NKG2D ligands in tumor immunity: two sides of a coin
Jinyu Zhang et al.
FRONTIERS IN IMMUNOLOGY (2015)
Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma
F. Q. Yang et al.
ACTAS UROLOGICAS ESPANOLAS (2014)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma
Lucas Ferrari de Andrade et al.
CANCER RESEARCH (2014)
MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques
Shunji Ikeshita et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Immunological Visibility: Posttranscriptional Regulation of Human NKG2D Ligands by the EGF Receptor Pathway
Pierre Vantourout et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17
Guranda Chitadze et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis
Gang Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding
Leticia Huergo-Zapico et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
An six-amino acid motif in the α3 domain of MICA is the cancer therapeutic target to inhibit shedding
Xuanjun Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
Philippe Boutet et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
Human tumor-derived exosomes down-modulate NKG2D expression
Aled Clayton et al.
JOURNAL OF IMMUNOLOGY (2008)
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
Masahisa Jinushi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
Brett K. Kaiser et al.
NATURE (2007)
Soluble MICA in malignant diseases
S Holdenrieder et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma
L Raffaghello et al.
NEOPLASIA (2004)
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer
JD Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Cutting edge: Tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin
Y Hayakawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA
PW Li et al.
NATURE IMMUNOLOGY (2001)
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
V Groh et al.
NATURE IMMUNOLOGY (2001)
分享论文
